A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
NCT06248814
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatitis, Atopic
Interventions
DRUG:
BMS-986326
OTHER:
Placebo
Sponsor
Bristol-Myers Squibb